SITE011-0114

SITE011 (ITA) › SITE011-0114

SITE011-0114

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE011 (ITA) · Dr. Jansen
consented 2026-01-18

withdrawn

AEs

5

Serious

0

Dropout signal

–

Adverse events

5

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-01-25 (study day 186); relationship: not assessed

moderate assessed

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-10-26 (study day 95); relationship: NOT RELATED

mild assessed

Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-08-31 (study day 39); relationship: NOT RELATED

mild assessed

Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-08-28 (study day 36); relationship: not assessed

moderate assessed

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-08-27 (study day 35); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.